30-Second Sit-to-Stand Test for Assessing Functional Capacity in Juvenile Idiopathic Arthritis
NCT ID: NCT06609837
Last Updated: 2025-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
197 participants
OBSERVATIONAL
2024-09-30
2025-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
H0: 30SST is not an alternative tool for assessing functional capacity in patients with JIA.
H1: 30SST is an alternative tool for assessing functional capacity in patients with JIA.
The study will include 81 adolescent patients with oligoarticular/polyarticular JIA and 116 healthy adolescent between the ages of 12-18. The 6MWT, 30SST and 10 Stair Climb Test (10SCT) will be applied to the cases that meet the inclusion criteria to evaluate their functional capacity. Demographic data and test results of the participants will be recorded and evaluated with statistical analysis methods. We believe that alternative tests that can be used to evaluate functional capacity in patients with JIA will contribute to the literature as a result of this study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis
NCT06806774
Video-Based Task Oriented Activity Training in Patients With Juvenile Idiopathic Arthritis
NCT02954718
Determination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis
NCT03731520
Fatigue and Sleep in Children and Adolescents With Juvenile Idiopathic Arthritis: A Cross-Sectional Study
NCT03618680
Core Stabilization Training in Juvenile Spondyloarthropathy
NCT06546293
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usability and Validity Group
In order to evaluate the usability of the 30SST, the validity of the test will be examined. In order to determine its validity in assessing functional capacity, the correlation of 6 MWT and 10SCT will be examined.
No interventions assigned to this group
Healthy Control Group
For analysis the difference between JIA and healthy control regarding the 30SST, 6MWT and 10SCT statistical analysis will be performed.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having been diagnosed with JIA at least 6 months ago at the Istanbul Medical Faculty Pediatric Rheumatology Clinic for Usability and Validity Group
* Having a diagnosis of Oligoarticular/Polyarticular JIA for Usability and Validity Group
* Volunteer to participate in the study for both groups
Exclusion Criteria
* Having an additional chronic disease affecting the musculoskeletal system for both groups
* Having vision or hearing problems for both groups
* Having cognitive impairment at a level where the person cannot understand the commands given for both groups
* Having vision or hearing problems for both groups
* Having had a corticosteroid injection into the knee or ankle within the last week for both groups
* Difference in length in the lower extremities for both groups
12 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nilay Arman
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nilay Arman, Assoc. Prof.
Role: STUDY_DIRECTOR
Istanbul University - Cerrahpasa
Asena Yekdaneh, MSc. Pt.
Role: PRINCIPAL_INVESTIGATOR
Fenerbahçe University
Asya Albayrak, MSc. Pt.
Role: PRINCIPAL_INVESTIGATOR
Istanbul University - Cerrahpasa
Fatma Gül Demirkan, Dr.
Role: PRINCIPAL_INVESTIGATOR
Istanbul University
Özlem Akgün, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
Istanbul University
Nuray Aktay Ayaz, Prof.
Role: PRINCIPAL_INVESTIGATOR
Istanbul University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University-Cerrahpaşa
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NArmann
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.